Aerovate Therapeutics Revenue

Biotechnology Research • Waltham, Massachusetts, United States • 11-20 Employees

Aerovate Therapeutics revenue & valuation

Annual revenue	$941,105
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,100,000
Total funding	$72,600,000

Key Contacts at Aerovate Therapeutics

Donald Santel

Independent Director

Timothy Noyes

Chief Executive Officer

Kurt Strittmatter

Executive Director, Pharmacovigilance

Deep Jain

Director, Drug Safety & Pharmacovigilance

Christine Quaranto

Sr. Director, Clinical Operations

Company overview

Headquarters	930 Winter Street, Suite M-500, Waltham, MA 2451, US
Phone number	+16174432400
Website	aerovatetx.com
Employees	11-20
Socials

Aerovate Therapeutics Email Formats

Aerovate Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@aerovatetx.com), used 81.8% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@aerovatetx.com	81.8%
{first initial}{last name}	jdoe@aerovatetx.com	18.2%

About Aerovate Therapeutics

Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's initial focus is on advancing AV-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or PAH.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

Head

Senior

Employees by Department

Aerovate Therapeutics has 6 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Aerovate Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-09-06	4	$72,600,000

Funding Insights

$72,600,000

Total funding amount

$72,600,000

Most recent funding amount

Number of funding rounds

Aerovate Therapeutics Tech Stack

Discover the technologies and tools that power Aerovate Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Slick

JavaScript libraries

PWA

Miscellaneous

Animate.css

UI frameworks

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Bootstrap

UI frameworks

Yoast SEO

SEO

Google Tag Manager

Tag managers

Frequently asked questions

Aerovate Therapeutics is located in Waltham, Massachusetts, US.

You can reach Aerovate Therapeutics at +16174432400.

Aerovate Therapeutics generates an estimated annual revenue of $941,105. This revenue figure reflects the company's market position and business performance in its industry.

Aerovate Therapeutics has an estimated valuation of $3,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Aerovate Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Aerovate Therapeutics has raised a total of $72,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Aerovate Therapeutics

Donald Santel

Independent Director

Timothy Noyes

Chief Executive Officer

Kurt Strittmatter

Executive Director, Pharmacovigilance

Deep Jain

Director, Drug Safety & Pharmacovigilance

Christine Quaranto

Sr. Director, Clinical Operations

4.8